ELAB vs MGM · rev $2.0M vs P/E 64, rev $4.45B
Elevai Labs, Inc. Common Stock (ELAB) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
ELAB currently screens at market cap $6.5M. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the ELAB and MGM stock pages for the full models.
Not investment advice.